Search

everythinglearnresearchcommunity

for

Search:↓

Women with PCOS should have an oral glucose tolerance test for effective diabetes screening.

New treatments are needed for non-scarring alopecia due to current limitations.

Combining different treatments can help manage Polycystic Ovary Syndrome (PCOS) effectively.

Both individual and combined treatments of tofacitinib and corticosteroids can help regrow hair in moderate-to-severe alopecia areata, but ongoing treatment may be necessary.

Patients with fewer past treatments for alopecia areata respond better to baricitinib.

Genetics can help tailor treatments for male pattern hair loss, improving outcomes like stabilization or modest regrowth.

Tofacitinib effectively treated a woman's complex autoimmune and autoinflammatory disorders.

Combination therapy is better for long-term control and outcomes in type 2 diabetes.

The article concludes that a balance is needed between individual healthcare needs and societal resources when it comes to lifestyle drugs, with a call for compassionate policy application.

The document concludes that treating skin conditions should include psychological care and a multidisciplinary approach is essential for effective management.

Certain herbal combinations in traditional Chinese medicine might be effective for treating hair loss, focusing on liver or stomach health.

Current treatments for Alopecia Areata don't fully meet patients' needs, indicating a need for better therapies.

Key proteins and potential drugs for treating alopecia areata were identified.

The girl's hair loss is due to trichotillomania, which may improve with behavioral therapy or a combination of treatments.

Gilles de la Tourette syndrome is treatable, with behavioral therapy as a recommended first option and other treatments available for more severe cases.

Combining medications with scalp care and lifestyle changes boosts hair growth and reduces medication side effects.

The document suggests a personalized treatment plan for alopecia areata based on the patient's age and hair loss severity, using a range of therapies ranked by effectiveness and safety.

Tofacitinib improved ulcerative colitis, skin ulcers, and hair loss in a patient who didn't respond well to other treatments.

High-dose steroid pulse therapy effectively regrows hair in severe multifocal alopecia areata.

Different treatments for skin conditions were found to be effective and generally safe, with biologics recommended as the first choice for generalized pustular psoriasis.

Combining light therapy with certain substances improves hair growth in people with hair loss.

WNMFDDA effectively predicts drug-disease associations.

Intramuscular triamcinolone and pulse therapy with oral predonine are effective for alopecia areata with manageable side effects, but better relapse prevention is needed.

Medications have become the main treatment for enlarged prostate symptoms, replacing surgery and watchful waiting.

Hormone treatments can help with women's skin and hair disorders, but they need careful monitoring and more research.

Clomipramine may significantly reduce hair-pulling in Trichotillomania, but more research is needed on treatments and early onset cases.

Skin and hair-picking disorders are common and need both skin and mental health treatments.

Higher CSF 5-HIAA levels may predict better response to serotonin re-uptake inhibitors in trichotillomania.

Folliculotropic mycosis fungoides has unique molecular features and cell interactions that could guide targeted therapy.

Modern therapies, like fractional laser, effectively treat telogen effluvium.